Technophage creates LX Bio: a new company to ensure the industrialization of biologics
Technophage’s plans for the next few years have been revealed in a brand new article in Portuguese Weekly Journal “Expresso”. The biopharma is moving forward with the creation of a new company that will be able to ensure the industrialization of pioneering drugs for...
Another take on TP-102 Phase I/IIa Clinical Trial by Jornal Expresso
During the development of TP-102 a lot of journals published pieces describing this great Technophage’s milestone. This year, Jornal Expresso, described the efforts made by the company to reach Phase I/IIa Clinical Trial with TP-102 in Israel. If you did not get...
Technophage granted with the ‘COTEC Innovative Status 2021’
Technophage is proud to announce that it has recently been granted with the ‘COTEC Innovative Status 2021’. COTEC Portugal is the main Portuguese business association for the promotion of business innovation and technological cooperation. The COTEC...